Aktie A060590 CTCBIO INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen CTCBIO Inc.

Aktien

A060590

KR7060590007

A060590

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 20.05.2024 		% 5 Tage % 1. Jan.
8.620 KRW -4,86 % Intraday Chart für CTCBIO Inc. +6,42 % -19,44 %
24.04. Koreanische Zuckerimporte brechen um 14% ein, da Diabetesfälle zunehmen MT
21.03. CTCBIO Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Korean Sugar Imports Plunge 14% as Diabetes Cases Surge
CTCBIO Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
An unknown buyer agreed to acquire an unknown minority stake in CTCBIO Inc. for KRW 20 billion.
CTCBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
An unknown buyer agreed to acquire 12.57229% stake in CTCBIO Inc. for KRW30 billion.
CTCBIO Inc. announced that it has received KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
CTCBIO Inc. announced that it expects to receive KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
CTCBIO Inc. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd
CTCBIO Inc. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd
CTCBIO Inc. announced that it has received KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., KB Securities Co.,Ltd, Mirae Asset Daewoo Co., Ltd., Shinhan Investment Corp.
CTCBIO Inc. announced that it expects to receive KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., KB Securities Co.,Ltd, Mirae Asset Daewoo Co., Ltd., Shinhan Investment Corp. other investors
CTCBIO Inc. announced that it has received KRW 20 billion in funding from Korea Investment Partners Co. Ltd.
CTCBIO Inc. announced that it expects to receive KRW 20 billion in funding from Korea Investment Partners Co. Ltd. and other investors
CTCBIO., Inc.'s Equity Buyback announced on August 8, 2014 has expired.
CTCBIO., Inc.(KOSDAQ:A060590) added to Russell Global Index
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology from CTCBIO Inc
CTCBIO., Inc.'s Equity Buyback Plan Extended till August 4, 2015.
CTCBIO., Inc. cancelled the acquisition of a Factory in Ansan City from SK Chemicals Ltd.
Tranche Update on CTCBIO., Inc.'s Equity Buyback Plan announced on August 8, 2014.
CTCBIO., Inc. acquired drug manufacturing division of SK Chemicals Co.,Ltd.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A060590 Aktie
  4. Nachrichten CTCBIO Inc.
  5. Andere Sprachen